Landau–Kleffner syndrome
| Landau–Kleffner syndrome | |
|---|---|
| Other names | Infantile acquired aphasia, acquired epileptic aphasia, aphasia with convulsive disorder |
| Landau–Kleffner syndrome is characterized by aphasia and an abnormal EEG | |
| Specialty | Neurology, psychiatry |
| Symptoms | Aphasia, inattention, hyperactivity, aggression, anxiety, seizures |
| Usual onset | Ages 3 to 7 |
| Duration | Lifelong |
| Treatment | Speech therapy, medication |
| Medication | Anticonvulsants, corticosteroids |
| Prognosis | Variable |
Landau–Kleffner syndrome (LKS), also called infantile acquired aphasia, acquired epileptic aphasia, or aphasia with convulsive disorder, is a rare neurological syndrome that develops during childhood.
It is named after William Landau and Frank Kleffner, who characterized it in 1957 with a diagnosis of six children.